| Code | 0329D | ||||||||||
| MA number | 18/0022/19-S | ||||||||||
| Product Form: | tbl plg 60x500 mg (blis.Al/PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.01.2019 |
| Validity: | 29.01.2024 |
| MA renewed: | Renewal application submitted |
| PIL: |
PIL_Metformin Teva XR_10.2022.pdf
|
| SPC: |
SPC_Metformin Teva XR_10.2022.pdf
|
| Safety feature | Yes |
| Data update: | 20.05.2020 |
